[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Application (Infant Formula, Functional Food & Beverages, Food Supplements), By Region, And Segment Forecasts, 2020 - 2027

February 2020 | 120 pages | ID: H02896F2F38EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 48 Business Hours

The global human milk oligosaccharides market size is anticipated to reach USD 101.5 million by 2027, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 23.0% over the forecast period. Increasing awareness regarding the functions and health benefits associated with Human Milk Oligosaccharides (HMO) is expected to fuel its demand over the forecast period.

Changing consumer lifestyles and their increasing concerns regarding health and wellness are some of the other prominent factors driving the demand for HMOs around the world. Human milk oligosaccharides in functional food and beverage products and food supplements can help the treatment of certain disorders and high-risk health conditions, which in turn is anticipated to boost the product demand. However, high costs associated with the product may challenge the market growth over the forecast period.

Human milk oligosaccharides is a major source of sialic acid, which is an essential part of the plasma membrane of nerve cells. Over 150 structurally diverse HMOs are available in nature. Moreover, scientists have been trying to develop various structures of HMOs synthetically, for use in the food industry-most particularly infant formulas and medical nutrition. These synthetically produced HMOs are safe for consumption by infants (who cannot be breastfed), as well as children and adults.

Human milk oligosaccharides find application in infant formula, functional food and beverages, and food supplements, among others. Increasing health awareness along with the rising consumption of infant formula is likely to boost the growth of the HMO market over the forecast period. The consumption of HMOs has contributed significantly to bring about a considerable reduction in the global infant mortality rate over the years. As per the United Nations International Children’s Education Fund (UNICE) the under-five mortality rate was one per 11 children in 1990 which dropped to one per 26 children in 2018.

Infant formula is the largest and fastest-growing application segment for human milk oligosaccharides. High infant mortality rate and rising concerns regarding health and safety are the factors likely to boost the market growth over the forecast period. HMOs play a key role in the proper development of infants. They fight life threatening infections and are also responsible for the proper development of the brain and gut.

Human milk oligosaccharides are also increasingly utilized in pharmaceutical applications. Furthermore, the prebiotic effects of HMOs make them suitable to be use in functional foods and beverages and food supplements. Functional foods and beverages is the second-largest application segment of HMOs. The demand for HMOs in designing infant formulas is increasing because of the beneficial properties, such as prevention from infection, memory enhancement, brain development, prebiotic effects, and improvement of gut health.

Asia Pacific is expected to be a lucrative market for human milk oligosaccharides and is expected to account for a significant share of the global HMO market revenue by 2027. The increasing demand for infant formulas and functional food and beverages as well as the rapidly growing pharmaceutical industry is expected to positively influence the market growth over the forecast period.

Recent years have witnessed various developments in the infant formula space with prominent end-use companies launching new and innovative products. For instance, in April 2019, Nestl? S.A., a Switzerland-based food and beverage company, introduced three new products in U.K., namely, SMA Advanced Follow-on Formula, SMA Advanced Growing up Milk, and SMA Advanced Infant Formula. These products contained artificial HMOs and were intended for infants who were not breastfed. Such developments within the infant formula sector are likely to drive the demand for human milk oligosaccharides in near future.

Further key findings from the report suggest:
  • In terms of application, the infant formula segment is expected to expand at a CAGR of 23.4% over the forecast period. Challenges associated with breast-feeding, such as personal comfort, time, diet, and frequency of feedings have led the increase in the consumption of infant formula, contributing to the segment growth
  • Incorporation of HMOs in functional food and beverages promote the growth of good bacteria and eliminates harmful bacteria including salmonella, listeria, and campylobacter
  • Growing consumption of functional foods and beverages for improving gut health and overall immunity is expected to have significant impacts on the demand for human milk oligosaccharides over the forecast period
  • Distribution agreements, capacity expansions, and investments for the development of low-cost technologies are some of the major strategies adopted by the prominent market players to establish strong competitive positions in the HMO market
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
  1.3.1. Purchased Database
  1.3.2. GVR’s Internal Database
  1.3.3. Secondary Sources & Third-Party Perspectives
  1.3.4. Primary Research
1.4. Information Analysis
  1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights

CHAPTER 3. HUMAN MILK OLIGOSACCHARIDES MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
  3.3.1. Major Raw Material Trends
  3.3.2. Manufacturing Trends
3.4. Technology Overview
3.5. Regulatory Framework
3.6. Vendor Selection Criteria Analysis
3.7. Aerosol Market – Market dynamics
  3.7.1. Market driver Analysis
  3.7.2. Market Restraint Analysis
  3.7.3. Industry Challenges
3.8. Business Environment Analysis: Human Milk Oligosaccharides Market
  3.8.1. Industry Analysis – Porter’s
    3.8.1.1. Supplier Power
    3.8.1.2. Buyer Power
    3.8.1.3. Substitution Threat
    3.8.1.4. Threat from New Entrant
    3.8.1.5. Competitive Rivalry
  3.8.2. PESTEL Analysis
    3.8.2.1. Political Landscape
    3.8.2.2. Environmental Landscape
    3.8.2.3. Social Landscape
    3.8.2.4. Technology Landscape
    3.8.2.5. Economic Landscape
    3.8.2.6. Legal Landscape
  3.8.3. Major Deals & Strategic Alliances Analysis
    3.8.3.1. Joint Ventures
    3.8.3.2. Mergers & Acquisitions
3.9. Market Entry Strategies

CHAPTER 4. HUMAN MILK OLIGOSACCHARIDES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

4.1. Human Milk Oligosaccharides: Application movement analysis, 2019 & 2027
4.2. Infant Formula
  4.2.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
4.3. Functional Food & Beverages
  4.3.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
4.4. Food Supplements
  4.4.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
4.5. Others
  4.5.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)

CHAPTER 5. HUMAN MILK OLIGOSACCHARIDES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

5.1. SWOT Analysis
  5.1.1. North America
  5.1.2. Europe
  5.1.3. Asia Pacific
  5.1.4. Central & South America
  5.1.5. Middle East & Africa
5.2. Human Milk Oligosaccharides: Regional movement analysis, 2019 & 2027
5.3. North America
  5.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
  5.3.2. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD ‘000)
  5.3.3. U.S.
    5.3.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.3.3.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.3.4. Canada
    5.3.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.3.4.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.3.5. Mexico
    5.3.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.3.5.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
5.4. Europe
  5.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
  5.4.2. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD ‘000)
  5.4.3. Germany
    5.4.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.4.3.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.4.4. U.K.
    5.4.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.4.4.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.4.5. France
    5.4.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.4.5.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
5.5. Asia Pacific
  5.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
  5.5.2. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD ‘000)
  5.5.3. China
    5.5.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.5.3.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.5.4. Japan
    5.5.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.5.4.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
  5.5.5. India
    5.5.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.5.5.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
5.6. Central & South America
  5.6.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
  5.6.2. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD ‘000)
  5.6.3. Brazil
    5.6.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.6.3.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)
5.7. Middle East & Africa
  5.7.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
  5.7.2. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD ‘000)
  5.7.3. UAE
    5.7.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD ‘000)
    5.7.3.2. Market Estimates and Forecasts, By Application , 2016 - 2027 (Tons) (USD ‘000)

CHAPTER 6. HUMAN MILK OLIGOSACCHARIDES MARKET: COMPETITIVE ANALYSIS

6.1. Key Global Players, Their Initiatives, & Their Impact on the Market
6.2. Participant Categorization
6.3. Vendor Landscape
  6.3.1. List of key distributors & channel partners
6.4. Public Companies
  6.4.1. Company Market Position Analysis
  6.4.2. Competitive Dashboard Analysis
    6.4.2.1. Market Differentiators
  6.4.3. SWOT Analysis
6.5. Private Companies
  6.5.1. Innovators/Emerging Company
  6.5.2. Geographical Presence
  6.5.3. Company market position analysis

CHAPTER 7. COMPANY PROFILES

7.1. Inbiose NV
  7.1.1. Company Overview
  7.1.2. Financial Performance
  7.1.3. Product Benchmarking
  7.1.4. Strategic Initiatives
7.2. Elicityl S.A
  7.2.1. Company Overview
  7.2.2. Financial Performance
  7.2.3. Product Benchmarking
  7.2.4. Strategic Initiatives
7.3. Jennewein Biotechnologie GmbH
  7.3.1. Company Overview
  7.3.2. Financial Performance
  7.3.3. Product Benchmarking
  7.3.4. Strategic Initiatives
7.4. Glycom A/S
  7.4.1. Company Overview
  7.4.2. Financial Performance
  7.4.3. Product Benchmarking
  7.4.4. Strategic Initiatives
7.5. Medolac Laboratories
  7.5.1. Company Overview
  7.5.2. Financial Performance
  7.5.3. Product Benchmarking
  7.5.4. Strategic Initiatives
7.6. ZuChem Inc
  7.6.1. Company Overview
  7.6.2. Financial Performance
  7.6.3. Product Benchmarking
  7.6.4. Strategic Initiatives
7.7. Glycosyn LLC
  7.7.1. Company Overview
  7.7.2. Financial Performance
  7.7.3. Product Benchmarking
  7.7.4. Strategic Initiatives
LIST OF TABLES

Table 1 Human milk oligosaccharides (HMO) market - Driver analysis
Table 2 Human milk oligosaccharides (HMO) market - Restraint analysis
Table 3 2’FL Specifications
Table 4 2’FL Key Suppliers
Table 5 2’FL Patents
Table 6 3’FL Specifications
Table 7 3’FL Key Suppliers
Table 8 3’FL Patents
Table 9 3’-Sialyllactose (3’SL) Specifications
Table 10 3’-Sialyllactose (3’SL) Suppliers
Table 11 3’-Sialyllactose (3’SL) Patents
Table 12 6’SL Specifications
Table 13 6’SL Key Suppliers
Table 14 6’SL Patents
Table 15 LNT - Specifications
Table 16 LNT Suppliers
Table 17 LNT Patents
Table 18 LNnT - Specifications
Table 19 LNnT Suppliers
Table 20 LNnT Patents
Table 21 Global HMO market estimates and forecast in infant formula, 2016 - 2027 (Tons) (USD ‘000)
Table 22 Global HMO market estimates and forecast in infant formula, by region, 2016 - 2027 (Tons)
Table 23 Global HMO market estimates and forecast in infant formula, by region, 2016 - 2027 (USD’000)
Table 24 Global HMO market estimates and forecast in functional food & beverages, 2016 - 2027 (Tons) (USD ‘000)
Table 25 Global HMO market estimates and forecast in functional food & beverages, by region, 2016 - 2027 (Tons)
Table 26 Global HMO market estimates and forecast in functional food & beverages, by region, 2016 - 2027 (USD’000)
Table 27 Global HMO market estimates and forecast in food supplements, 2016 - 2027 (Tons) (USD ‘000)
Table 28 Global HMO market estimates and forecast in food supplements, by region, 2016 - 2027 (Tons)
Table 29 Global HMO market estimates and forecast in food supplement, by region, 2016 - 2027 (USD’000)
Table 30 Global HMO market estimates and forecast in others, 2016 - 2027 (Tons) (USD ‘000)
Table 31 Global HMO market estimates and forecast in others, by region, 2016 - 2027 (Tons)
Table 32 Global HMO market estimates and forecast in others, by region, 2016 - 2027 (USD’000)
Table 33 North America HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 34 North America HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 35 North America HMO market estimates and forecasts, by application, 2016 - 2027 (USD’ 000)
Table 36 U.S HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 37 U.S HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 38 U.S HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 39 Canada HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 40 Canada HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 41 Canada HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 42 Mexico HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 43 Mexico HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 44 Mexico HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 45 Europe HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 46 Europe HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 47 Europe HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 48 U.K. HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 49 U.K. HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 50 U.K. HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 51 Germany HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 52 Germany HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 53 Germany HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 54 France HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 55 France HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 56 France HMO market estimates and forecasts, by application, 2016 - 2027 (USD’000)
Table 57 Asia Pacific HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 58 Asia Pacific HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 59 Asia Pacific HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 60 China HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 61 China HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 62 China HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 63 Japan HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 64 Japan HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 65 Japan HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 66 India HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 67 India HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 68 India HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 69 Central & South America HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 70 Central & South America HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 71 Central & South America HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 72 Brazil HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 73 Brazil HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 74 Brazil HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 75 MEA HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 76 MEA HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 77 MEA HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
Table 78 UAE HMO market estimates and forecasts, 2016 - 2027 (Tons) (USD ‘000)
Table 79 UAE HMO market estimates and forecasts, by application, 2016 - 2027 (Tons)
Table 80 UAE HMO market estimates and forecasts, by application, 2016 - 2027 (USD ‘000)
LIST OF FIGURES

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Primary research process
Fig. 4 Primary research approaches
Fig. 5 Human milk oligosaccharides (HMO) market snapshot, 2019 (USD’ 000)
Fig. 6 Human milk oligosaccharides (HMO) market segmentation
Fig. 7 Human milk oligosaccharides (HMO) market volume and revenue estimates and forecast, 2016 – 2027 (USD Thousand)(Tons)
Fig. 8 Value chain analysis
Fig. 9 Raw material outlook
Fig. 10 Market dynamics
Fig. 11 Global trade in dairy products, 2016 and 2017 (Thousand Tons)
Fig. 12 Global dietary supplements market, 2016 - 2024 (USD ‘000)
Fig. 13 Human milk oligosaccharides - Key opportunities prioritized
Fig. 14 Human milk oligosaccharides - Strategy framework
Fig. 15 Human milk oligosaccharides - Porter’s analysis
Fig. 16 Human milk oligosaccharides - PESTEL analysis
Fig. 17 Human milk oligosaccharides: Application movement & market share analysis, 2019 & 2027
Fig. 18 Human milk oligosaccharides: Regional movement & market share analysis, 2019 & 2027


More Publications